Alpha Teknova Inc TKNO
π Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-25 |
| Shares Out. | 53,610,000 |
| Website | teknova.com/ β |
| Phone | 13026587581 |
| Employees | 158 |
| Revenue | $12.2M |
| Gross Profit | $4.9M |
| Net Income | -$3.2M |
| Free Cash Flow | -$7.4M |
| Total Assets | $95.9M |
| Total Liabilities | $33.3M |
| Equity | $62.6M |
About Alpha Teknova Inc
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Alpha Teknova Inc is a publicly traded company under the ticker symbol TKNO on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
13 analysts (2026-09-01)
